Article info
Arrhythmias and sudden death
Original article
Net clinical benefit of warfarin in individuals with atrial fibrillation across stroke risk and across primary and secondary care
- Correspondence to Professor Harry Hemingway, Farr Institute of Health Informatics Research, University College London, 222 Euston Road, London NW1 2AD, UK; h.hemingway{at}ucl.ac.uk
Citation
Net clinical benefit of warfarin in individuals with atrial fibrillation across stroke risk and across primary and secondary care
Publication history
- Received April 29, 2016
- Revised July 21, 2016
- Accepted July 30, 2016
- First published August 31, 2016.
Online issue publication
October 25, 2017
Article Versions
- Previous version (25 October 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/